Kneu Health: Pioneering Health Tech Innovation, Recognized in Prestigious Programs

At Kneu Health, our commitment to health technology innovation has been recognised in several UK and global programmes and partnerships, including JLABS, Health Innovation East, and Propel@YH. These acknowledgments reflect our commitment to advancing healthcare through groundbreaking technology and solutions.

JLABS: Globally Showcasing Innovation

Johnson and Johnson Innovation JLABS is a global life science network for health tech innovators. Kneu Health's selection into the JLABS ecosystem helps us to develop our health technology innovation and drive advancements in patient care in partnership with one of the world's leading health care organisations.

Health Innovation East: Positive Health Impact for Patients

Our partnership with Health Innovation East helps us to improve patient care for people in the East of England and as part of a national NHS network. This partnership emphasizes our commitment to driving positive change within the NHS by leveraging innovative solutions that positively impact patient outcomes and healthcare efficiency.

Propel@YH Programme: Turbo-charging digital health innovation

Propel@YH is Health Innovation Yorkshire & Humber's digital accelerator for innovative healthcare startups. Being recognized within this programme highlights our commitment to bringing innovative digital health and patient solutions to the Yorkshire and Humber region's population and the wider health economy.

Being recognized in the Propel@YH Programme, JLABS, and Health Innovation East partnership reinforces Kneu Health's role as a pioneering force in health tech innovation for people with Parkinson's and dementia. These acknowledgments reflect our relentless pursuit of innovative solutions that enhance patient care and revolutionize healthcare delivery.

About Kneu Health

Kneu Health is pioneering a new model of precision neurology for Parkinson's and dementia: care that is proactive, compassionate, and designed for the realities of everyday life. Built on one of the most advanced longitudinal datasets in Parkinson's care — the Oxford Parkinson's Disease Centre Discovery Cohort — Kneu's smartphone-based platform turns structured at-home assessments into actionable insights, enabling clinicians to detect decline earlier and act before symptoms escalate. The technology analyzes speech, movement, memory, and cognition in just minutes a day, using trained models to generate predictive scores and digital biomarkers that inform treatment and care. Kneu is working with leading U.S. health systems to expand access, ease workforce strain, and set a new standard for brain health monitoring.